India's leading drug makers, through the Indian Pharmaceutical Alliance, have petitioned the Supreme Court to enable police and drug inspectors to investigate and prosecute counterfeit drug manufacturers. They argue that without proper enforcement and protection, the prevalence of counterfeit drugs has increased, affecting public health and India's global pharmaceutical reputation.
